Ochre Bio to Participate in Upcoming Global Industry Conferences - May 09, 2023

09 May 2023
www.biospace.com
OXFORD, England--(BUSINESS WIRE)-- Ochre Bio, an innovator in chronic liver disease medicine development, has announced its participation in upcoming investor and industry conferences, sharing expert perspectives and insights across liver disease and RNA therapeutics, building and scaling startups, and the future of medicine. BioEquity Europe Location: Dublin, Ireland Date/Time: May 15, 12.50 BST Talk title: Ochre Bio – Pioneering novel RNAi therapeutics for liver diseases Presenter: Jack O’Meara – CEO & Co-Founder, Ochre Bio The session recording will be available to watch for 30 days after the event. Please register for the event here UK BioIndustry Association - Startup Festival Location: London Date/Time: May 25, 14.00 BST Panel: To New Horizons – Building Your Overseas Presence Speaker: Jack O’Meara – CEO & Co-Founder Ochre Bio Register for the event here RNA and the future of medicine Location: McGill University, Montreal Canada Date/Time: June 2, 10.10 EDT Session: The emerging RNA Industry and its ethical challenges Speaker: Dr. Quin Wills - CSO & Co-Founder, Ochre Bio Register for the event here About Ochre Bio Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases. Using a combination of deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications. Visit: . View source version on businesswire.com: Contacts Media: Jessica Smith | jessica@somx.co.uk Source: Ochre Bio View this news release online at:
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.